Company page

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. (Ticker: RIGL) is a public company based in America, with a market capitalization of approximately $680 million. The company focuses on the development of innovative therapies for various diseases. Rigel is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.